Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Kwality Pharmaceuticals Ltd.

Kwality Pharma

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
30 06 2021 Half Yearly Results & Audited Results
22 10 2021Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended on 30th September, 2021
10 11 2021 Inter alia, to consider and approve the Migration of the Company from BSE SME Platform to Main Board of BSE Limited subject to approval of shareholders and other matters related or incidental thereto.
28 05 2022 Half Yearly Results & Audited Results
13 08 2022 Quarterly Results
14 11 2022 Quarterly Results
14 02 2023 Quarterly Results
27 05 2023 Quarterly Results & Audited Results
10 08 2023 Quarterly Results
04 11 2023 Quarterly Results
06 02 2024 Quarterly Results
30 10 2024 Quarterly Results
31 01 2025 Quarterly Results
19 05 2025 Quarterly Results & Audited Results
11 08 2025 Quarterly Results
13 11 2025 Quarterly Results
12 02 2026 Quarterly Results

News

18-AUG-2025

Kwality Pharmaceuticals gets registration for Bleomycin in Mexico

This approval further strengthens its expansion into highly regulated markets, reinforcing its commitment to delivering quality oncology products globally

02:10 PM
02-JAN-2025

Kwality Pharmaceuticals gets nod to start pre-clinical toxicity studies for Erythropoietin product

This milestone marks a significant step forward in its commitment to expanding its biologics portfolio and addressing critical healthcare needs

03:29 PM
24-DEC-2024

Kwality Pharmaceuticals gets product approval for Tamoxifen tablet in South Africa

This approval further strengthens its presence in the High Regulated and global oncology market

03:59 PM
26-NOV-2024

Kwality Pharmaceutical gets approval for manufacturing and sale of PEGylated-Asparaginase

L-Asparaginase is an E. coli-derived enzyme primarily used in the treatment of acute lymphoblastic leukemia

03:59 PM
06-NOV-2024

Kwality Pharmaceuticals gets nod for Leuprorelin Acetate 11.25 mg vial powder & solvent for injectable suspension

Kwality Pharma will supply the first three validation batches in December

05:44 PM
24-APR-2023

Kwality Pharmaceuticals gets EU GMP approval for Himachal Pradesh facility

The EU-GMP Approval is the result of stringent quality and compliance norms followed at Kwality Pharma across all departments

05:58 PM
28-DEC-2022

Bulgarian Drug Agency accepts Kwality Pharmaceuticals’ application for EU Audit visit of HP plant

The status of GMP Compliance will be updated once the inspection will be completed with their accreditation

09:57 AM
21-DEC-2022

Kwality Pharmaceuticals gets approval from Brazil’s ANVISA

The approval grants access to the Company to register and market its products at the large and growing Brazilian Pharmaceutical Market

04:00 PM
Enrich money logo